Factors that influence clinicians’ decisions to decrease active surveillance monitoring frequency or transition to watchful waiting for localised prostate cancer: a qualitative study

• Lisa M Lowenstein,
• Robert J Volk,
• Noah J Choi,
• Karen E Hoffman,
• Stacy Loeb

Affiliations

Lisa M Lowenstein

Health Services Research, The University of Texas MD Anderson Cancer Center Division of Cancer Prevention and Population Sciences, Houston, Texas, USA

Robert J Volk

Health Services Research, The University of Texas MD Anderson Cancer Center Division of Cancer Prevention and Population Sciences, Houston, Texas, USA

Noah J Choi

Health Services Research, The University of Texas MD Anderson Cancer Center Division of Cancer Prevention and Population Sciences, Houston, Texas, USA

Karen E Hoffman

Radiation Oncology, MD Anderson Division of Radiation Oncology, Houston, Texas, USA

Stacy Loeb

Urology, Population Health, New York University, New York, New York, USA